chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On 11-NOV-2013 the patient was vaccinated with M-M-R II injection (dose, lot and expiry date unknown). The  M-M-R II doses were exposed to 52 Fahrenheit since 07-NOV-2013. No adverse effect was reported. This is 2 of 2 reports from the same source. Additional information has been requested.
I did not have an adverse reaction to the vaccine. I tested positive for COVID-19 via home test on 07/23/2022. I had scratchy throat, no fever, chills, extremely tired, sneezing and terrible sinus pressure. As of today I feel tired and I have a raspy throat.
History:  pt got J&J COVID-19 vaccine on 4/5 and the next day, pt developed left-sided headache and body ache, like as if having a cold, per pt, and gradually the headache got better every day but it didn't go away completely, now steady for a week w/o daily improvement, bilateral, but also with left neck pain with certain rotation of neck, with vague intermittent bilateral blurry vision and bilateral intermittent non-pulsatile tinnitus (says pt heard some gobbled unclear noise during meeting thru the speaker earlier), w/o paresthesia/weakness in limbs, here for eval.  Sometimes, pt has felt dizzy when standing up.  Denies use of any meds currently and denies prior history of headaches, prior concussion/head injury.
Pain from injection went to chest, headache, now has cough with runny nose, itchy throat, no temperature.
Info has been received from an RN concerning an 11 year old white male student with asthma and a non-verbal learning disability who on 3/12/98 was vaccinated with the 1st dose of varicella virus vaccine live. There was no illness at the time of vaccination. The RN reported that on 1/11/05, the pt broke out at school with approximately 30 lesions and had a runny nose. The pt was noted to be afebrile. Medical attention was not sought and no lab/diagnostic tests were performed. On 1/17/06, the pt's lesions and runny nose resolved. Additional info has been requested.
Information has been received from a registered pharmacist concerning a female patient who in March 2011, was vaccinated with ZOSTAVAX (Merck) (lot#, dose, and route were not specified). The pharmacist reported that a female patient developed "palsy of her head" after receiving ZOSTAVAX (Merck) in March 2011. The patient reported that her head started shaking "shortly after" receiving the vaccine. The patient stated that the shaking was a nuisance and would like it to stop. It was unspecified if the patient sought medical attention. At the time of the report, the patient's events persisted. Upon internal review, "palsy of her head" was determined to be an other important medical event. Additional information has been requested.
Flu shot was given Sat 10/22/16. Had resultant reaction. Right arm had area around injection site that was indurated, red, warm and painful. Right axillary area was very painful with swollen lymph node in armpit.
Higher then normal morning glucose reading/Blood sugar levels spiking; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 75 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 04Mar2021 12:45 (Batch/Lot number: unknown) at the age of 75 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Diabetes" (ongoing). The patient's concomitant medications were not reported. The following information was reported: BLOOD GLUCOSE INCREASED (non-serious) with onset 07Mar2021, outcome "not recovered", described as "Higher then normal morning glucose reading/Blood sugar levels spiking". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of blood glucose increased.  Additional information: There are no known allergies.The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. patient had nor received any other medication within 2 week of vaccination as reported.Reporter reporting an increase in blood glucose after the covid vaccine. Patient had his first dose on 04Mar2021 and his 2nd shot 25Mar2021. Starting on 07Mar2021 and on, it has been spiking about 25 points higher than than normal. The glucose level went up after the second shot 20-25 points. Patient said it is unusual for it to go up, His previous Internist that retired told him that he would have times during the year like Christmas and holidays that he would see his levels go up. He was advised to increase his Metformin 1000 mg dose and add 1/2 tablet daily to help correct the increase. Patient normally takes 1000mg twice daily for a total of 2000mg. With the increase the total dose is 2500mg daily Reporter confirmed that he is adding 1/2 tablet of Metformin daily since 07Mar2021.Caller confirmed total daily dose as 2500 mg per day. Caller has seen that a fever and the rest of the stuff could happen, but it not that. Caller is asking could the spiking be caused by the Pfizer injection?Pharmacy bottle not available to Report at the time of the report for lot, and exp.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
About 12 hours after vaccine given, woke up from sleeping all night with joint pain all over, low back pain worse SI joint pain, ,etc.  I have an autoimmune disease that causes back and joint pain.  It seems that I had a ?flare? or worsening in condition following the injection.  Arm hurt where vaccine given is also but that happens with most all vaccines.  That was not the reason I am writing this up.  Writing it up to the the inflamed state I was in.
Swollen lymph nodes in the lower superficial cervical and supraclavicular area on the right side, swelling went away after 8 days.  Small amount of red pinpoint dots on both lower legs, which did not worsen and went away after 2 days.
High calcium and parathyroid hormone levels detected 7/20/21 and 7/23/21, retested and reconfirmed 10/21/21 and showed high liver enzymes as well.
Graves' disease; This is a Regulatory Authority report.  A 50-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for Covid-19 immunisation; Covid-19 vaccine (DOSE 2, MANUFACTURER UNKNOWN), for Covid-19 immunisation. The following information was reported: BASEDOW'S DISEASE (medically significant), 5 days after the suspect product(s) administration, outcome "unknown", described as "Graves' disease". Clinical course: patient developed hyperthyroid symptoms 5 days after receiving a 3rd booster dose of P?zer mRNA SARS-CoV- 2 (P?zer) vaccination. Labs a week later the vaccine: TSH 0.01 u[IU]/mL (0.4 - 5.0 u[IU]/mL), free T4 (FT4) 3.1 ng/dL (0.6 - 1.2 ng/dL), Thyroid-Stimulating Immunoglobulin (TSI) 3.2 (<1.3), consistent with diagnosis of graves' disease. None of the patient had a personal or family history of thyroid disease. Therapeutic measures were taken as a result of basedow's disease. She responded well to methimazole 20 mg daily.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the known the information available the Causal relation between the event BASEDOW'S DISEASE and suspect drug cannot be excluded completely The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202201287741 Same article/ drug and different patient;US-PFIZER INC-202201287742 Same article/ drug and different patient;US-PFIZER INC-202201287890 Same article/ drug and different patient;
Information has been received from a health professional concerning a 54 year old female who on 05-OCT-2007 was vaccinated IM with a 0.5 ml dose of PNEUMOVAX.  Concomitant therapy included SYNTHROID.  On approximately 06-OCT-2007 (during the week end) the patient developed fever of 103 F, swelling of the entire left arm and red blotches on the arm.  The patient had a hard time getting the fever down with OTC medications during the day but the fever did break over the night.  On Monday 08-Oct-2007, the patient still nursed a low grade temperature.  Unknown medical attention was sought.  The patient's outcome was unknown.  No product quality complaint was involved.  Additional information has been requested.
pt had a few hives on 7/10/07-later in day after the Gardasil. Hives were worse on 7/11/07 with itch throat. Went to ER-given Benadryl and Prednisone x 7 days. pt also given an Epi Pen for future use.
Swollen lower lip,  injection site swelling on Right Deltoid.  Dr. prescribed Ibuprofen 400 mg TID  5 days PRN for pain,  Benadryl Allergy  25 mg 1 tab BID for 5 days as needed,  Discontinue Enalapril/HCTZ  start Amlodipine 10 mg  once per day  to replace Enalapril/HCTZ
Vaccinated on Thursday. Took Friday off work because of lethargy, bouts of nausea. Had a fever high of 101.8 last night (Friday). Vaccination location was very sore and uncomfortable, with an overall weakness and lack of energy. I had no appetite for two days, tried eating yesterday but immediately became nauseous, so I could not. Will try again today, Saturday.  Today,  my temperature is back to normal and the soreness, nausea, and lethargy, are mostly gone. My strength seems almost back to normal. The only treatment I had two days was sleeping on and off, an hour or two at a time. I expect at this rate, that I will be back to normal tomorrow. I did notify my doctors office via website message.
Pt became shaky, lightheaded and vomited X 1. Reports chills. No chest pain or arm pain. Remained alert but shaking chills continued X 10 minutes. 911 called and was transported to ED.
14 days after vaccine, large red rash on left upper arm, hot and sore.   Low-grade fever x approximately 24 hrs;  chills x app. 36 hrs,;   legs heavy and weak x app. 48 hrs.;  enlarged left axillary lymph nodes x app. 3 days; following blood draw at 18 days, unusual pain and swelling at site in left arm lasting app. 5 days
pt recv vax & felt faint, exp a h/a & was pale & very dizzy;
Report 2002000693-1 describes a 34-year-old female who did not respond to the hepatitis B recombinant vaccine (Engerix-B) immunization series. Medical history, concurrent conditions, and concurrent medications were not specified. On 11/12/2001, the pt received her 3rd injection of Engerix-B. In January 2002, approx 2 months post-vaccination, "titers" revealed that the pt had not seroconverted.
Pt describes feeling severe chills, fever of 101.4, inability to walk overnight, and delirium yesterday afternoon and overnight last night.  She reports chills causing contortions, inability to walk, she stool up and fell down immediately, and hallucinations. She describes thinking she was using a computer when she was not.
Patient reports pain in her arm that started the day of vaccination and has persisted until today (11/12/21) with some reported loss of mobility.
Information has been received from an office manager (health professional) referring to multiple unspecified patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored RECOMBIVAX HB (lot # K021444, expiration date 17-SEP-2016, strength, dose and route were unknown). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a registered nurse reporting on an adult patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history or concomitant medication. On 15-JUN-2018, the patient received a pediatric dose of VAQTA for prophylaxis, lot # N019924, expiration date 02-SEP-2018 (dose and route of administration were not reported). No adverse effects reported.
Patient has a rash, red, warm reaction under the PNEUMOVAX shot. It was hard for her to move her arm but is getting better the next day.
Redness, pain, swelling and arm. It?s also warm in that area. Watery burning eyes. Headache.
Mild vaso-vagal, diaphoretic, dizzy.  BP 118/78, HR 64, RR 16.  Taken to med bay, laid down, A&O x4, patient stabilized, vitals stable.  Proper ambulation. Patient stable and released from vaccination site.  Recommended that patient lay down for second dose.
Lips, tongue became swollen, c/o tightness in chest immediately,mom immediately phoned MD; Atarax in home, MD ordered 3 tsp immediately & 3 tsp in half an hour; sx started to subside approx 20min p/1st dose; All sx gone by AM;
Within 24 hours, I developed a scratchy throat, bronchitis-like symptoms, and an itchy rash at the injection site..  After a few days, I began to experience swollen and painful lymph nodes mainly in the opposite arm of the injection site in my armpit and under my right breast.  I then developed extreme burning pain in both breasts and nipples.  Both were swollen and hypersensitive to touch.  I was seen by my doctor and diagnosed with enlarged lymph nodes under my arm and in my breasts.  I had minimal effects from the first and second injections other than fatigue achiness.
menstrual period did not come; A spontaneous report was received from a healthcare professional concerning a 46-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events spotting: menstrual period, heaviness: menstrual period, menstrual period did not come.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 22 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 039K20A) via unknown route for prophylaxis of COVID-19 infection. On 23 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 024M20A) via unknown route for prophylaxis of COVID-19 infection.  On 23 Feb 2021, the patient experienced the event(s) spotting: menstrual period, heaviness: menstrual period. On 22 Jan 2021, the patient experienced the event(s) menstrual period did not come.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), spotting: menstrual period, heaviness: menstrual period, menstrual period did not come was unknown.
I had a Covid vaccine from my job on 3/4/2021. I started feeling symptoms 2 days after my vaccination and everyday I am experiencing new symptoms. I was in the ER one week after the vaccine with numnes on the entire left side of my body, when I was admitted to the hospital I had many tests done, I tested positive for Covid , i had MRIs , everyday I would lose feeling in different parts of my body. After staying in the hospital 5 days I was diagnosed with GBS and sent home. Three days after I came home I had new symptoms I couldn?t walk my legs w re paralyzed. I had to go back to the hospital. I stayed  in the hospital 5 days.I was diagnosed one more time  with Post-Vaccination Guillain-Barré Syndrome (GBS) .My symptoms are still coming back to my spine and head. I am not able to keep my head up for long. They did all the test again and the neurologists confirmed one more time that I have GBS syndrome after receiving the vaccine.
severe chills; fever up to 102.5; headache; nausea; swollen armpit lymph node(s); achey; dizzy feeling; sore arm; Weak to walk; This is a spontaneous report from a contactable consumer (patient, self-reported). A 58-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EWO171 and expiry date was no reported), via an unspecified route of administration, administered in Arm right, on 07May2021, as DOSE 2, SINGLE for COVID-19 immunization at Pharmacy or drug store (at the age of 58-year-old) at Pharmacy or drug store. Patient was not pregnant at the time of vaccination. The patient was not pregnant at the time of vaccination. The patient medical history included enlarged thyroid. Patient had no known allergy. The patient was not diagnosed with COVID prior vaccination. Concomitant medications included dietary supplements and herbal remedies. The patient did not receive any other vaccine in four weeks. Patient previously received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EWO153 and expiry date was not reported), via an unspecified route of administration, administered in Arm right, on 16Apr2021, (at the age of 58-year-old) as DOSE 1, SINGLE for COVID-19 immunization and experienced major sore arm, unable to sleep well and tired. The patient was not tested for COVID post vaccination. On 07May2021 at 23:00, the patient experienced severe chills, fever up to 102.5, headache, nausea could barely eat toast, swollen armpit lymph nodes, achey, weak to walk, a bit dizzy feeling and sore arm. The patient underwent lab test and procedure included fever (Body temperature) 102.5 on 07May2021. The patient did not receive any treatment for the events. Outcome of the events were not recovered.  No follow-up attempts are possible. No further information is expected.
Leg weakness, muscle pain, somnolence, vertigo, unsteadiness 05/15/07-records received for DOS 3/26-3/31/07-Presented to ER with increased blood pressure weakness in legs. BP 210/106. Assessment Hypertension. R/O rhabomyois subsequently ruled out.HX of stent placement 2 weeks prior and returned 1 week later with complaints of arm pain. Developed coughing and weakness in both knees. Feels lightheaded. Sleeps all the time. DX:Acute hypertension, angiotensis-converting enzyme induced cough and somnolence. Clinical presentation highly consistent with PMR which may explain stiffness muscle discomfort and possible vertigo.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old male patient received BNT162b2 (BNT162B2), on 14Apr2021 at 13:15 as dose number unknown, single (Lot number: ER8727) at the age of 60 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Lyme" (unspecified if ongoing); "babesiosis" (unspecified if ongoing). No known allergy. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "recovering" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, suspected covid-19: received Paxlovid for Covid-19 treatment from 30Jun2022 to 04Jun2022.
PT ARRIVED AT CHECK WINDOW WAS PALE IN COLOR AND FELT FAINT. PT LOWERED TO FLOOR. VITAL SIGNS WNL. MONTIOTRED UNTIL PT FELT BETTER.
About an hour after I had my Pneumococcal Vaccine I experienced shortness of Breath that lasted several hours -not severe enough to seek medical treatment --ALso - and this is really odd - yesterday which was the 8th day since I was vaccinated  I had pain and redness in my arm where I was given the shot - the area was  hot to the touch. I took a picture of it since I thought that that was so unusual.
101 degree Fahrenheit Fever, malaise, tachycardia, dizziness, fatigue.  Experienced when alarm sounded at 6:00am the day after receiving the COVID-19 Vax injection.
Diagnosed with a herniated disk; Sore right arm; This spontaneous case was reported by a consumer and describes the occurrence of INTERVERTEBRAL DISC PROTRUSION (Diagnosed with a herniated disk) and VACCINATION SITE PAIN (Sore right arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE PAIN (Sore right arm). On 06-Apr-2021, the patient experienced INTERVERTEBRAL DISC PROTRUSION (Diagnosed with a herniated disk). At the time of the report, INTERVERTEBRAL DISC PROTRUSION (Diagnosed with a herniated disk) and VACCINATION SITE PAIN (Sore right arm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Apr-2021, Magnetic resonance imaging: abnormal (abnormal) Patient had an MRI done and was diagnosed with a herniated disc..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications taken by the patient were not provided.  Treatment information was not provided.  Reporter reported that she does not feel the event herniated disk  had anything to do with the vaccine.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow up received on 28 Jun 2021 had outcome of the event updated as recovered.
No adverse event - Pharmacist was working through a busy Covid-19 booster clinic, and did not notice the birthdate of the patient until vaccine was already administered - pt only 17 when Moderna is indicated for 18 years old and older. Only Pfizer should have been used, but none was available during this clinic - pharmacist should have notified pt at time of interaction.